Can we well assess the relative efficacy and tolerability of a new drug versus others at the time of marketing authorization using mixed treatment comparisons? A detailed illustration with escitalopram

OBJECTIVE: To assess the variation of relative efficacy and tolerability of an antidepressant versus others based on both pre-marketing (registration studies) and post-marketing studies versus pre-marketing studies only in patients with major depressive disorder. METHODS: The relative efficacy and t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Mark Access Health Policy
Main Authors: Llorca, Pierre-Michel, Lançon, Christophe, Brignone, Mélanie, Painchault, Caroline, Rive, Benoit, Toumi, Mondher, François, Clément
Formato: Artigo
Idioma:Inglês
Publicado em: Co-Action Publishing 2015
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802698/
https://ncbi.nlm.nih.gov/pubmed/27123184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3402/jmahp.v3.26776
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados